Dopamine hydrochloride and Isosorbide mononitrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dopamine hydrochloride (dopamine hydrochloride) and Isosorbide mononitrate (isosorbide mononitrate). Common drug interactions include abdominal pain lower among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Dopamine hydrochloride and Isosorbide mononitrate. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Dopamine hydrochloride?

Dopamine hydrochloride has active ingredients of dopamine hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 1,789 Dopamine hydrochloride users. Check the latest studies of Dopamine hydrochloride.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.



On Jul, 20, 2026

28 people who take Dopamine hydrochloride and Isosorbide mononitrate together, and have interactions are studied.

Dopamine hydrochloride and Isosorbide mononitrate drug interactions.

What are the common drug interactions of Dopamine Hydrochloride and Isosorbide Mononitrate, by gender? *:

female:

  1. Abdominal pain lower
  2. Abnormal sensation in eye
  3. Bilirubin conjugated increased
  4. Blood bilirubin increased
  5. Blood creatinine increased
  6. Blood glucose increased
  7. Blood magnesium decreased
  8. Blood urea increased
  9. Blood urine present
  10. Haemoglobin decreased

male:

  1. Pneumonia
  2. Lymphocyte count decreased
  3. Blood glucose increased
  4. Cough
  5. Cytomegalovirus infection
  6. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  7. Abdominal distension
  8. Alanine aminotransferase increased
  9. Anaemia (lack of blood)
  10. Bk virus infection

What are the common drug interactions of Dopamine Hydrochloride and Isosorbide Mononitrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Urinary tract infection
  2. Venous thrombosis (blood clot (thrombus) that forms within a vein)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Abdominal distension
  5. Alanine aminotransferase increased
  6. Anaemia (lack of blood)
  7. Bk virus infection
  8. Blood albumin decreased
  9. Blood triglycerides increased
  10. Blood urea increased

40-49:

  1. Blood glucose increased
  2. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  3. Blood creatine increased
  4. Cough
  5. Cytomegalovirus infection
  6. Lymphocyte count decreased
  7. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  8. Protein urine present
  9. Red blood cells urine positive
  10. Hyperlipidaemia (presence of excess lipids in the blood)

50-59:

  1. Myelosuppression (a decrease in the production of blood cells)
  2. Pneumonia

60+:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Pneumonia
  3. Pyrexia (fever)
  4. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  5. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  6. Ventricular fibrillation (abnormally irregular heart rhythm)
  7. Acute respiratory failure
  8. Blood ph decreased
  9. Breath sounds absent
  10. Drug ineffective

What are the existing conditions these people have? *

  1. High Blood Pressure: 12 people, 42.86%
  2. Urination - Excessive Volume: 11 people, 39.29%
  3. Sedation: 9 people, 32.14%
  4. Pneumonia: 9 people, 32.14%
  5. Anaesthesia: 8 people, 28.57%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 8 people, 28.57%
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 25.00%
  8. Productive Cough: 7 people, 25.00%
  9. Inflammation: 5 people, 17.86%
  10. Diarrhea: 5 people, 17.86%

* Approximation only. Some reports may have incomplete information.

Do you take Dopamine hydrochloride and Isosorbide mononitrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dopamine hydrochloride and Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dopamine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dopamine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dopamine hydrochloride and isosorbide mononitrate (the active ingredients of Dopamine hydrochloride and Isosorbide mononitrate, respectively), and Dopamine hydrochloride and Isosorbide mononitrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: